The present invention relates to a .beta..sub.3 adrenergic receptor agonist of formula I: ##STR00001## or a pharmaceutical salt thereof; which is useful for treating Type II diabetes and/or obesity.

 
Web www.patentalert.com

< Tricyclic compound having spiro union

< NK1 antagonists

> Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles

> Therapeutic table
~ 00295